Skip to main content

Advertisement

Table 2 Hormone and biomarker levels of TART patients before and after treatment

From: Sonographic features of the testicular adrenal rests tumors in patients with congenital adrenal hyperplasia: a single-center experience and literature review

Patient No. Treatment LH (IU/L) FSH (IU/L) PRL (ng/mL) P (ng/mL) T (ng/mL) E (pg/mL) ACTH(pg/ml) 17-OHP(ng/ml) HCG AFP
Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post   
1 Dexamethasone 5.1 8.21 2.96 4.44 12.6 / 10.94 33.06 553.4 7.17 20 38 282 / 29.5 / <5 2.4
2 Hydrocortisone 20.1 / 0.5 / / / 20 / 18.7 / 99.48 / 157 / 299.9 / <0.5 1.9
3 Dexamethasone 14.34 12.79 17.29 24.95 / / 5.44 2.85 1.71 2.46 19 12 539 41.2 84.5 3.92 / /
4 Hydrocortisone 6.41 0 6.42 0 7.24 35 / / 25.51 3.66 38 240.6 32.4 14.6 40.1 19.68 0 1.7
5 Hydrocortisone 4.44 8.59 8.21 10.45 / / 33.06 5.27 2.17 6.23 38 27 410 516 DS: 184.6 DS: 200.6 / /
6 Hydrocortisone 2.66 11.38 6.3 6.22 / / 15.3 6.68 5.54 6.29 27 23 291 798 DS: 89.3 DS: 74.4 / /
7 Prednisone 0.96 1.88 5.21 5.49 / / 2.7 4.88 3.59 4.36 5 35 254 213 DS: 29.0 DS: 36.1 <0.1 1.7
8 Hydrocortisone 0.18 1.10 0.76 0.21 / / 39 0.39 2.07 < 0.1 18 < 5 373 170 64.31 4.47 0.8 1.1
  1. Abbreviations: LH luteinizing hormone, FSH follicle-stimulating hormone, PRL prolactin, P progesterone, T testosterone, E estrogen, ACTH adrenocorticotropic hormone, 17-OHP 17 hydroxyprogesterone, HCG human chorionic gonadotropin, AFP alpha fetoprotein, Pre pre-treatment, Post post-treatment, DS dehydroepiandrosterone-s